Latest DEF 14A proxy statements

Premier, Inc. is reminding stockholders to vote FOR the proposed merger with Patient Square Capital at the upcoming special meeting on November 21, 2025.

Greenwich LifeSciences, Inc. has filed a Definitive Proxy Statement (SCHEDULE 14A) with the U.S. Securities and Exchange Commission.

Elon Musk expresses concerns over corporate governance and the influence of proxy advisory firms, stating he needs 25% voting power to ensure the safe development of AI and robotics at Tesla.

Nabors Energy Transition Corp. II amends its proxy statement to seek shareholder approval for an indefinite extension of its existence and to allow withdrawal of trust account interest for operating expenses, while abandoning its business combination pursuit.

Kindly MD, Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, a corporate reincorporation to Delaware, and auditor ratification.

PROS Holdings, Inc. stockholders are set to vote on a $23.25 per share all-cash merger with Thoma Bravo, representing a significant premium over recent trading prices.

Kindly MD, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to vote on director elections, corporate reincorporation, auditor ratification, and meeting adjournment.

Glucotrack, Inc. reconvenes its Special Meeting of Shareholders on November 7, 2025, to vote on a $20 million Equity Purchase Agreement with Sixth Borough Capital Fund LP.

Palisade Bio, Inc. filed a supplement to its proxy statement, correcting the number of outstanding common shares for its upcoming Special Meeting due to recent warrant exercises.

Katapult Holdings, Inc. has raised $65 million through convertible preferred stock, repaid its term loan, amended its revolving credit facility, and appointed new directors to its board.

WideOpenWest, Inc. provides an update on its proposed acquisition by DigitalBridge and Crestview Partners, confirming the definitive proxy statement filing and setting a December 3, 2025, shareholder meeting for the merger vote.

Jack in the Box Inc. announced the appointment of Mark King and Alan Smolinisky as independent directors to its Board, expanding it to 10 members, following a cooperation agreement with GreenWood Investors, LLC.

AmpliTech Group, Inc. issued a supplement to its definitive proxy statement to correct a typographical error regarding the number of outstanding common shares for its upcoming annual meeting.

Organovo Holdings, Inc. announced its 2023 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, an employee stock purchase plan, and a corporate charter amendment.

Hologic, Inc. announced robust fiscal fourth-quarter results with significant revenue and EPS growth, alongside a definitive agreement to be acquired by Blackstone and TPG for up to $79 per share.

TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, outlining key proposals including director elections, executive compensation, auditor ratification, and an increase in authorized common stock.

Permian Basin Royalty Trust unit holders to vote on a proposal to reform the Trust Indenture at a special meeting on December 16, 2025.

THOR Industries, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on December 17, 2025, outlining key proposals including director elections, auditor ratification, executive compensation, and an amended equity plan.

PB Bankshares, Inc. will merge with Norwood Financial Corp in an 80% stock, 20% cash transaction, unanimously recommended by PB Bankshares' board.

Streamex Corp. announced Nasdaq approval for continued listing and will reconvene a special shareholder meeting on November 4, 2025, to vote on an acquisition proposal.

Metsera, Inc. issued a statement refuting Pfizer's litigation, asserting it is an attempt to lower the acquisition price amidst a competing proposal from Novo Nordisk.

Surge Components, Inc. announces its Annual Meeting of Stockholders on November 25, 2025, to elect directors, ratify auditors, and extend its stockholder rights plan.

Greenwich LifeSciences, Inc. announced its 2025 Annual Meeting of Stockholders to elect directors and ratify its independent accounting firm, alongside detailed executive compensation and corporate governance updates.

High Income Securities Fund announces its Annual Meeting of Shareholders on December 15, 2025, to elect six Trustees and address other business.

Kindly MD, Inc. is holding its 2025 Annual Meeting to vote on key proposals including the re-election of directors, a strategic conversion to a Delaware corporation, and the ratification of its independent auditor.

374Water Inc. is calling a Special Meeting of Stockholders to vote on a reverse stock split aimed at regaining compliance with Nasdaq's minimum bid price requirement and facilitating future financing.

VivoSim Labs, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 16, 2025, where key proposals include director elections, auditor ratification, and advisory votes on executive compensation.

N2OFF, Inc. announced its annual stockholder meeting to vote on director elections, a significant increase in its share incentive plan, and an advisory vote on director share grants.

TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, to vote on director elections, executive compensation, auditor ratification, and a significant increase in authorized common stock.

THOR Industries reports $258.6 million net income and $577.9 million cash from operations in Fiscal Year 2025, increasing its dividend despite a prolonged RV industry downcycle.